Bone marrow hematopoietic stem cell regulatory pathways (HSC regulatory pathways)

Bone marrow hematopoietic stem cell (HSC) regulatory pathways comprise the intricate network of intrinsic and extrinsic signals that maintain the balance between HSC quiescence, self-renewal, and differentiation within the specialized bone marrow niche (1.3.5, 1.4.3). Key signaling axes include the CXCL12/CXCR4 pathway, which is essential for HSC homing and mobilization, and the SCF/c-Kit pathway, which supports stem cell survival and maintenance (1.3.3, 1.4.3). Other critical pathways involve Wnt, Notch, Hedgehog, and TGF-β signaling, which integrate environmental cues from stromal cells, osteoblasts, and endothelial cells to regulate the stem cell pool (1.2.2, 1.3.5). Dysregulation of these pathways is a hallmark of hematological malignancies such as leukemia and myelodysplastic syndromes, where aberrant signaling drives the survival and uncontrolled proliferation of malignant stem cells (1.1.2, 1.4.3). Therapeutic strategies often target specific components of these pathways, such as using CXCR4 antagonists like plerixafor to mobilize HSCs for transplantation or BCL2 inhibitors like venetoclax to induce apoptosis in leukemic stem cells (1.1.2, 1.3.2). Understanding the spatial and temporal regulation of these pathways is vital for developing novel treatments in oncology and regenerative medicine (1.2.1, 1.3.1).

Other names

HSC niche signalingHematopoietic stem cell niche regulationHSC self-renewal pathwaysBone marrow microenvironment signaling

Drugs targeting these pathways act by antagonizing receptors like CXCR4 to mobilize stem cells into the peripheral blood, stimulating growth factor receptors to promote progenitor expansion, or inhibiting anti-apoptotic proteins like BCL2 to selectively eliminate malignant stem cell populations (1.1.2, 1.3.2, 1.3.3).